Episode 18 – Dr. Sharon Cohen Deconstructs the Aducanumab Data From CTAD

Saving Minds

English - December 11, 2019 18:48 - 32 minutes - 44.1 MB - ★★★★★ - 30 ratings
Medicine Health & Fitness Business Investing alzheimers parkinsons pharma promis Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Episode 17 – The Data Behind Biogen's Recent Decision with Dr. James Kupiec

Next Episode: Episode 19 – Dr. Stephen Salloway, Rhode Island’s Man of the Year, on a brighter future for Alzheimer’s disease

This week Shanti and Elliot talk to Dr. Sharon Cohen, director of Toronto Memory Program. They discuss the recent news surrounding aducanumab, as well as Dr. Cohen's recent trip to CTAD.